Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P49
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.95% |
| Q3 2025 | 8.17% |
| Q2 2025 | -23.66% |
| Q1 2025 | -13.29% |
| Q4 2024 | -7.85% |
| Q3 2024 | -47.40% |
| Q2 2024 | 26.81% |
| Q1 2024 | -50.92% |
| Q4 2023 | -73.85% |
| Q3 2023 | 35.66% |
| Q2 2023 | -0.51% |
| Q1 2023 | -17.78% |
| Q4 2022 | -28.77% |
| Q3 2022 | -21.08% |
| Q2 2022 | 41.53% |
| Q1 2022 | -22.75% |
| Q4 2021 | -16.72% |
| Q3 2021 | 35.27% |
| Q2 2021 | -15.54% |
| Q1 2021 | -177.92% |
| Q4 2020 | 54.27% |
| Q3 2020 | 7.69% |
| Q2 2020 | 21.52% |
| Q1 2020 | 3.15% |
| Q4 2019 | 0.39% |
| Q3 2019 | -1.89% |
| Q2 2019 | 1.06% |
| Q1 2019 | -42.04% |
| Q4 2018 | -25.52% |
| Q3 2018 | 11.12% |
| Q2 2018 | 1.92% |
| Q1 2018 | -20.13% |
| Q4 2017 | 27.81% |
| Q3 2017 | -29.21% |
| Q2 2017 | 23.64% |
| Q1 2017 | -91.50% |
| Q4 2016 | -3.83% |
| Q3 2016 | 25.21% |
| Q2 2016 | -5.90% |
| Q1 2016 | -7.18% |